Profile data is unavailable for this security.
About the company
Talis Biomedical Corporation is a molecular diagnostic company. The Company is focused on advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care.
- Revenue in USD (TTM)408.00k
- Net income in USD-51.03m
- Incorporated2013
- Employees99.00
- LocationTalis Biomedical Corp1375 West Fulton Market, Suite 700CHICAGO 60607United StatesUSA
- Phone+1 (650) 433-3000
- Fax+1 (302) 636-5454
- Websitehttps://talisbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aditxt Inc | 329.75k | -43.31m | 3.12m | 47.00 | -- | 0.0027 | -- | 9.47 | -3,088.09 | -3,088.09 | 12.12 | 131.74 | 0.0185 | 0.6082 | 0.8393 | 7,015.96 | -242.33 | -192.78 | -1,548.63 | -321.59 | -46.09 | -- | -13,105.77 | -7,208.65 | 0.0458 | -3.53 | 0.5084 | -- | -30.90 | -- | -18.11 | -- | -- | -- |
| Avenue Therapeutics Inc | 0.00 | -5.87m | 3.13m | 3.00 | -- | 0.5469 | -- | -- | -3.02 | -3.02 | 0.00 | 4.00 | 0.00 | -- | -- | 0.00 | -177.94 | -186.91 | -- | -287.70 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -192.15 | -- | -- | -- |
| InMed Pharmaceuticals Inc | 4.60m | -7.68m | 3.15m | 13.00 | -- | 0.2285 | -- | 0.6851 | -1.33 | -1.33 | 0.6027 | 1.03 | 0.3546 | 2.44 | 14.99 | -- | -59.20 | -92.09 | -69.92 | -113.17 | 23.94 | -- | -166.94 | -543.29 | 3.78 | -- | 0.00 | -- | 11.18 | -- | 3.42 | -- | -19.10 | -- |
| Alaunos Therapeutics Inc | 7.00k | -19.13m | 3.18m | 1.00 | -- | 0.8428 | -- | 454.00 | -11.95 | -11.95 | 0.0044 | 2.36 | 0.0004 | -- | 1.75 | 7,000.00 | -117.34 | -74.83 | -143.58 | -89.57 | -- | -- | -273,271.40 | -10,508.06 | -- | -- | 0.00 | -- | -99.83 | -49.08 | 6.86 | -- | -15.56 | -- |
| Petros Pharmaceuticals Inc | 4.12m | -20.64m | 3.18m | 21.00 | -- | 0.3664 | -- | 0.7724 | -6.54 | -6.54 | 1.00 | 0.988 | 0.1529 | 0.6795 | 1.89 | 196,223.30 | -26.18 | -32.43 | -39.25 | -68.05 | 70.21 | 62.04 | -171.23 | -201.70 | 1.26 | -- | 0.4539 | -- | -2.83 | -16.15 | 31.06 | -- | -- | -- |
| Entero Therapeutics Inc | 0.00 | -9.69m | 3.27m | 15.00 | -- | 0.2219 | -- | -- | -15.29 | -15.87 | 0.00 | 24.07 | 0.00 | -- | -- | 0.00 | -20.88 | -295.92 | -26.29 | -1,599.51 | -- | -- | -- | -- | -- | -2,709.72 | 0.0025 | -- | -- | -- | -7.55 | -- | -- | -- |
| Talis Biomedical Corp | 408.00k | -51.03m | 3.30m | 99.00 | -- | 0.0678 | -- | 8.08 | -28.02 | -28.02 | 0.224 | 26.69 | 0.0042 | -- | 1.53 | 4,121.21 | -52.13 | -68.18 | -57.23 | -74.22 | 95.10 | -- | -12,506.37 | -1,615.96 | -- | -- | 0.00 | -- | -55.65 | -2.24 | 45.13 | -- | -1.83 | -- |
| Bio Path Holdings Inc | 0.00 | -11.60m | 3.32m | 10.00 | -- | 1.58 | -- | -- | -17.91 | -17.91 | 0.00 | 0.5655 | 0.00 | -- | -- | 0.00 | -199.23 | -70.80 | -321.87 | -76.87 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -15.94 | -- | -- | -- |
| ProtoKinetix, Inc. | 0.00 | -369.97k | 3.38m | 0.00 | -- | 8.33 | -- | -- | -0.0011 | -0.0011 | 0.00 | 0.0012 | 0.00 | -- | -- | -- | -78.67 | -696.88 | -85.20 | -785.51 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 78.22 | -- | 10.78 | -- |
| NuCana PLC (ADR) | 0.00 | -36.42m | 3.41m | 25.00 | -- | 0.6947 | -- | -- | -227.74 | -227.74 | 0.00 | 2.17 | 0.00 | -- | -- | 0.00 | -91.91 | -41.01 | -177.64 | -48.07 | -- | -- | -- | -- | -- | -- | 0.0689 | -- | -- | -- | 13.71 | -- | -21.70 | -- |
| Helix BioMedix, Inc. | 2.07m | -2.58m | 3.45m | 8.00 | -- | 2.21 | -- | 1.67 | -15.60 | -15.60 | 12.48 | 6.95 | 0.8047 | 1.87 | 4.55 | 258,238.80 | -100.64 | -146.31 | -120.73 | -173.57 | 68.96 | 30.80 | -125.06 | -527.12 | 1.69 | -14.57 | 0.00 | -- | 122.07 | 92.80 | 67.73 | -- | -29.08 | -- |
| Pasithea Therapeutics Corp | 0.00 | -16.37m | 3.46m | 8.00 | -- | 0.2137 | -- | -- | -14.98 | -14.99 | 0.00 | 15.49 | 0.00 | -- | -- | 0.00 | -58.66 | -- | -62.74 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -32.23 | -- | -- | -- |
Data as of Nov 11 2024. Currency figures normalised to Talis Biomedical Corp's reporting currency: US Dollar USD
51.31%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Baker Bros. Advisors LPas of 08 Oct 2024 | 508.32k | 27.89% |
| BML Capital Management LLCas of 30 Sep 2024 | 248.70k | 13.64% |
| DME Capital Management LPas of 30 Jun 2024 | 149.05k | 8.18% |
| Prelude Capital Management LLCas of 30 Jun 2024 | 14.93k | 0.82% |
| G1 Execution Services LLCas of 30 Jun 2024 | 11.61k | 0.64% |
| BlackRock Advisors LLCas of 30 Sep 2024 | 1.44k | 0.08% |
| Tower Research Capital LLCas of 30 Jun 2024 | 877.00 | 0.05% |
| Steward Partners Investment Advisory LLCas of 30 Jun 2024 | 147.00 | 0.01% |
| Osaic Wealth, Inc. (Investment Management)as of 30 Jun 2024 | 84.00 | 0.01% |
| Larson Financial Group LLCas of 30 Jun 2024 | 14.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
